• HOME
  • Business
  • Stock
  • Property
  • Market
  • Economy
  • Crypto
Language:
×
  • Home
  • tags Lyfius Pharma

Lyfius Pharma News

Business

Aurobindo Pharma's Lyfius Temporarily Halts Pen-G Production After Fire Incident in Kakinada Plant

Christopher Adams 29 Apr, 2025

Aurobindo Pharma's Lyfius Pharma has temporarily halted Pen-G production at its Kakinada plant after a fire incident, with no injuries reported and minimal impact expected on opera...

Popular News

  • Economy

    Fitch Warns: Rising US Tariffs Could Destabilize Asia-Pacific Banking Sectors in 2025

    16 Apr, 2025
  • Economy

    Swiss National Bank Slashes Interest Rates to Historic Low of 0.25% Amid Inflation Concerns

    20 Mar, 2025
  • Business

    NSDL's Mega IPO Set for July 30: A Rs 4,000 Crore Opportunity with a Rs 16,000 Crore Valuation

    25 Jul, 2025
  • Business

    Sanofi Reports Impressive 10.8% Surge in Q1 Net Sales, Reaching €9.9 Billion

    24 Apr, 2025
  • Business

    Aakash Educational Services Demands Investigation into Byju's Insolvency Proceedings Amid Alleged Discrepancies

    25 Mar, 2025
  • Business

    Uber Surprises with $11.5B Q1 Revenue, Yet Falls Short of Analyst Expectations

    07 May, 2025
  • Business

    Government and RBI Consider 'Cooling Off' Period to Combat Online Fraud Through Mule Accounts

    20 Jan, 2025
  • Economy

    Exclusive: WEF's Internal Probe Reveals Klaus Schwab's Decade of Misconduct and Questionable Expenses

    24 Jul, 2025

Newsletter

Subscribe Newsletter!

Stay ahead of the market – subscribe now for the latest insights and expert analysis delivered straight to your inbox!

About Us

  • EconWatcher.com is a comprehensive financial website dedicated to providing insights into economics, stocks, real estate, cryptocurrencies, markets, and business trends.
  • 15 Cliff St, New York NY 10038, USA
  • +91 234 567 8765
  • [email protected]

Popular Categories

  • Business (1M+)
  • Stock (1M+)
  • Property (1M+)
  • Market (1M+)
  • Economy (1M+)
  • Crypto (1M+)

Legal

  • Privacy Policy

  • Terms & Conditions

  • Contact Us

Copyright © 2022 All Rights Reserved.